提醒成功
搜索
| 产品规范 | |
|---|---|
| Type | In Vivo - Reseach Grade Antibody |
| Host | CHO cells |
| catalog# | B00064 |
| Application | Flow cytometry, animal model study |
| Aliases | Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 |
| Size/Concentration | 1mg/5mg/20mg |
| Isotype | Human IgG1 kappa |
| Storage | Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Human CEACAM5 |
| Formulation | PBS, pH 7.4 |
Description |
|---|
What is tusamitamab biosimilar research grade? Tusamitamab is a humanized IgG1-kappa monoclonal antibody targeting carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) which is overexpressed in tumors including non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), and is an attractive target for therapies based on CAR-T cell or/and ADCs. Tusamitamab ravtansine (SAR408701) is an antibody-drug conjugate (ADC) combining a humanized monoclonal antibody and a potent cytotoxic maytansinoid derivative (DM4) inhibiting microtubule assembly. Tusamitamab biosimilar uses the same protein sequences as the therapeutic antibody tusamitamab. |
Tusamitamab Biosimilar, Human CEACAM5 Monoclonal Antibody B00064
规格:
- 1mg
- 5mg
- 20mg
数量:
-
+
说明书:
¥2275
-
咨询
-
收藏

微信/QQ登录


首页